Nurami https://validator.w3.org/feed/docs/rss2.html Co-CEO Nora Nseir Featured in Calcalist Nurami Featured in LSI Weekly Recap Nurami Medical Announces Successful Completion of Phase 1 Milestones in EIC-Backed Grant for Artifix® Dural Repair Graft Nurami has closed a Series B Round Led by a Strategic Investor Nurami Medical Announces Appointment of Erez Rozenfeld as Chairman of the Board Contact Us Nurami Medical chosen for Blended Financing by the EIC About Us Nurami Medical attended the NASBS Annual Meeting 2026 Nurami Medical attended the Congress of Neurological Surgeons (CNS) Annual Meeting 2025 Nurami Atttended the Israeli Neurological Society’s annual meeting While we don’t have any open roles at the moment, we’re always happy to connect with talented professionals. Send your CV to: Job@Nurami-medical@com, and we’ll reach out when a suitable opportunity becomes available. Work with us Nurami to attend AANS 2025 in Boston in April Nurami to Attend NASBS 2025 in New Orleans Nora Nseir to Present at MedTech in Toronto Nurami welcomes Peter Stebbins, its new Executive Chair of the Board Products Nurami Accepted to the MedTech Innovator Program Nora Nseir Pitches at LSI 2023 Nurami made waves at CNS 2023 Iron Nation invests in Nurami Medical Nora Nseir selected among 4 finalists at the EU Woman Innovator 2019 New article published on ArtiFascia: Neural tissue tolerance to synthetic dural mater graft implantation – read more! Nurami Medical has been accepted to the In-Ventech Growth Stage Program News & Events Nurami seeks FDA, EU approval for soft tissue repair solution Nurami Medical Raises $5 Million Round Led by Almeda Ventures Nurami Medical at CNS 2022 Annual Meeting in San Francisco ArtiFascia® Receives 510K Clearance Nurami will be at annual CNS congress in Houston Nurami Medical finishes recruitment for tissue damage clinical trial Nurami Medical announces positive results from its brain surgery clinical trial Nurami Medical has been accepted to the In-Ventech Growth Stage Program A healing solution after brain surgery ArtiFascia Pivotal NEOART study has been initiated Great Appearance at AANS 2024 in Chicago Nurami Medical develops innovative sealants and surgical patches based on unique combinations of advanced bioactive materials and optimized, electrospun nanofiber scaffolds Nurami Medical was awarded the Seal of Excellence under the Horizon 2020 ArtiFasciaTM First-in-Human clinical study has been successfully completed Nurami’s first patent was granted in the US and China Henry Brem Joins Nurami Medical’s Scientific Advisory Board First ArtiFascia Dura repair procedures carried out in the US Terms of Use Nurami to Attend AANS 2024 in Chicago Privacy Policy Nurami Receives a $4M Investment Grant from the IIA Home